A genome-wide association study (GWAS) by Farrell et al. revealed that factors such as cortical expression of syntaxin 6 (STX6), RUNX family transcription factor 2 (RUNX2), and myelin-associated oligodendrocyte basic protein (MOBP) are linked with increased PSP risk [15]. The gene discussed is MOBP; the disease is supranuclear palsy, progressive, 1.